Avonex intramuscular injection 30 μg pen, from Biogen Japan, features Interferon beta-1a (genetically recombinant). This injectable drug (YJ code: 6399422G2023) is provided as 30μg in 0.5mL per kit and is used to treat relapsing forms of multiple sclerosis, including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease.
Avonex intramuscular injection 30 μg pen
Need more detailed information?
Contact TASAKI PHARMA for product sourcing, availability, or related support (English support available).